aztreonam has been researched along with Hemorrhagic Shock in 1 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Excerpt | Relevance | Reference |
---|---|---|
"To describe the pharmacokinetic profile of aztreonam and vancomycin hydrochloride in a clinically relevant experimental model of hemorrhagic shock and trauma." | 3.69 | Antibiotic pharmacokinetics following fluid resuscitation from traumatic shock. ( Boucher, BA; Croce, MA; Fabian, TC; McKindley, DS; Proctor, KG, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McKindley, DS | 1 |
Fabian, TC | 1 |
Boucher, BA | 1 |
Croce, MA | 1 |
Proctor, KG | 1 |
1 other study available for aztreonam and Hemorrhagic Shock
Article | Year |
---|---|
Antibiotic pharmacokinetics following fluid resuscitation from traumatic shock.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Disease Models, Animal; Female; Fluid Therapy; Hemodynami | 1995 |